Saxenda effectively manages weight by suppressing appetite, slowing gastric emptying and promoting insulin production. Saxenda, Wegovy and Zepbound (tirzepatide) are the only GLP-1 medications FDA-approved for weight loss. Other GLP-1s approved for Type 2 diabetes may produce weight loss, but they do not have FDA approval for that use. Using https://isaace947epz4.blogtov.com/profile